OraSure Technologies (NASDAQ: OSUR)
OraSure Technologies Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
OraSure Technologies Company Info
OraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment offer oral fluid diagnostic products and specimen collection devices. The DNAG segment produces specimen collection kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. The company was founded by Michael J. Gausling in May 2000 in and is headquartered in Bethlehem, PA.
News & Analysis
Why OraSure Technologies Stock Is Jumping Today
Investors applauded the diagnostics company's Q4 update.
Why OraSure Technologies Stock Is Soaring Today
The FDA granted Emergency Use Authorization for the company's at-home saliva collection device for coronavirus testing.
Why OraSure Stock Lost 16% in February
Lower demand from a key customer has reduced the company's sales outlook.
Is OraSure Technologies, Inc. a Buy?
The market for self-testing services has a lot of room to grow.
Why OraSure Technologies, Inc. Rallied 10.8% in December
Shares bounced back from their drubbing in November.
Why OraSure Technologies, Inc. Zoomed Higher Today
A large sale to a single customer has investors excited about the diagnostic company's prospects.
Is This Why OraSure Technologies, Inc. Is Tanking Today?
Shares plunged even though the company reported upbeat results. What gives?
Why OraSure Technologies, Inc. Jumped Higher Today
A solid second quarter from the diagnostic test maker.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.